Open · 27 days left
Belgium – Various medicinal products – Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
IMELDA VZW
Open procedure by IMELDA VZW, bids due 1 Dec 2026.
- Estimated value
- —
- Submission deadline
- 1 Dec 202610:00, Brussels time
- Procedure
- Open procedure
- CPV
- 33690000Various medicinal products
- Published
- 3 Nov 2026TED
Ask an AI about this tender
The question is already written. For the likely price and named rivals, connect Awardia to your assistant (address below).
How contested it usually is
Not enough past contracts from this buyer in this kind of work to show competition signals yet.
In your AI assistant, with Awardia
- Likely price range for this tender
- The companies that often bid here, with each one's win rate
- This buyer's recent awards, with winner, discount and number of bids
Connect Awardia to Claude or ChatGPT and ask: “Is tender 763149-2026 worth bidding for?”
https://awardia.app/mcp
Other open tenders in the same sector